24.38
price up icon1.33%   0.32
after-market Dopo l'orario di chiusura: 24.41 0.03 +0.12%
loading
Precedente Chiudi:
$24.06
Aprire:
$24.33
Volume 24 ore:
9.67M
Relative Volume:
0.94
Capitalizzazione di mercato:
$10.45B
Reddito:
$5.06B
Utile/perdita netta:
$-2.22B
Rapporto P/E:
-4.189
EPS:
-5.82
Flusso di cassa netto:
$-3.96B
1 W Prestazione:
-9.80%
1M Prestazione:
-1.06%
6M Prestazione:
-47.94%
1 anno Prestazione:
-80.00%
Intervallo 1D:
Value
$23.95
$24.98
Intervallo di 1 settimana:
Value
$23.70
$28.52
Portata 52W:
Value
$23.15
$170.47

Moderna Inc Stock (MRNA) Company Profile

Name
Nome
Moderna Inc
Name
Telefono
(617) 714-6500
Name
Indirizzo
325 BINNEY STREET, CAMBRIDGE
Name
Dipendente
5,800
Name
Cinguettio
@moderna_tx
Name
Prossima data di guadagno
2025-02-14
Name
Ultimi documenti SEC
Name
MRNA's Discussions on Twitter

Confronta MRNA con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
MRNA
Moderna Inc
24.38 10.45B 5.06B -2.22B -3.96B -5.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
429.60 128.25B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
547.67 63.70B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
569.12 39.07B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
258.35 33.27B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
235.94 27.58B 3.81B -644.79M -669.77M -6.24

Moderna Inc Stock (MRNA) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-03-13 Iniziato Citigroup Neutral
2025-02-18 Downgrade Barclays Overweight → Equal Weight
2025-01-29 Downgrade Goldman Buy → Neutral
2024-12-18 Downgrade Argus Buy → Hold
2024-12-10 Ripresa BofA Securities Underperform
2024-11-19 Iniziato Berenberg Hold
2024-11-18 Aggiornamento HSBC Securities Hold → Buy
2024-11-15 Iniziato Wolfe Research Underperform
2024-10-17 Iniziato Bernstein Mkt Perform
2024-09-13 Downgrade JP Morgan Neutral → Underweight
2024-09-13 Downgrade Jefferies Buy → Hold
2024-09-13 Downgrade Oppenheimer Outperform → Perform
2024-08-28 Aggiornamento HSBC Securities Reduce → Hold
2024-08-07 Aggiornamento Deutsche Bank Sell → Hold
2024-08-05 Downgrade RBC Capital Mkts Outperform → Sector Perform
2024-02-26 Downgrade HSBC Securities Hold → Reduce
2024-01-02 Aggiornamento Oppenheimer Perform → Outperform
2023-11-29 Iniziato Canaccord Genuity Hold
2023-11-03 Aggiornamento HSBC Securities Reduce → Hold
2023-11-02 Downgrade Deutsche Bank Hold → Sell
2023-08-04 Downgrade TD Cowen Outperform → Market Perform
2023-08-03 Downgrade Deutsche Bank Buy → Hold
2023-07-24 Iniziato William Blair Mkt Perform
2023-07-14 Iniziato HSBC Securities Reduce
2023-06-26 Aggiornamento UBS Neutral → Buy
2023-04-26 Iniziato Guggenheim Neutral
2023-03-13 Aggiornamento TD Cowen Market Perform → Outperform
2023-03-02 Iniziato RBC Capital Mkts Outperform
2023-02-24 Downgrade SVB Securities Market Perform → Underperform
2022-12-19 Aggiornamento Jefferies Hold → Buy
2022-12-14 Downgrade Chardan Capital Markets Buy → Neutral
2022-10-21 Aggiornamento SVB Leerink Underperform → Mkt Perform
2022-09-08 Aggiornamento Deutsche Bank Hold → Buy
2022-02-01 Aggiornamento Redburn Sell → Neutral
2022-01-26 Aggiornamento Deutsche Bank Sell → Hold
2022-01-21 Aggiornamento BofA Securities Underperform → Neutral
2022-01-21 Iniziato UBS Neutral
2021-12-07 Iniziato Cowen Market Perform
2021-11-09 Iniziato Wolfe Research Outperform
2021-10-22 Iniziato Deutsche Bank Sell
2021-10-15 Aggiornamento Piper Sandler Neutral → Overweight
2021-08-06 Downgrade Oppenheimer Outperform → Perform
2021-08-06 Downgrade Piper Sandler Overweight → Neutral
2021-07-15 Reiterato Jefferies Hold
2021-02-01 Downgrade BofA Securities Neutral → Underperform
2020-12-16 Downgrade Jefferies Buy → Hold
2020-12-16 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-12-09 Downgrade Needham Buy → Hold
2020-11-23 Iniziato Wells Fargo Equal Weight
2020-11-17 Downgrade BMO Capital Markets Outperform → Market Perform
2020-09-08 Downgrade SVB Leerink Mkt Perform → Underperform
2020-07-23 Iniziato SVB Leerink Mkt Perform
2020-07-20 Downgrade JP Morgan Overweight → Neutral
2020-07-13 Iniziato Jefferies Buy
2020-06-30 Iniziato Argus Buy
2020-06-08 Iniziato Barclays Overweight
2020-04-30 Iniziato BMO Capital Markets Outperform
2020-03-05 Downgrade BofA/Merrill Buy → Neutral
2019-12-03 Ripresa BofA/Merrill Buy
2019-10-25 Iniziato ROTH Capital Buy
2019-04-05 Iniziato Chardan Capital Markets Buy
Mostra tutto

Moderna Inc Borsa (MRNA) Ultime notizie

pulisher
05:31 AM

Moderna claims to have combined flu and COVID-19 vaccines - CBS News

05:31 AM
pulisher
05:01 AM

Kovitz Investment Group Partners LLC Sells 40,925 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

05:01 AM
pulisher
04:26 AM

Moderna study shows immune response in older adults for a new combo flu and COVID-19 shot - WKYT

04:26 AM
pulisher
02:07 AM

Moderna Stock: Analyst Estimates & Ratings - Nasdaq

02:07 AM
pulisher
02:01 AM

How effective will Moderna's combo Covid and flu mRNA shot be? - KSNV

02:01 AM
pulisher
01:36 AM

Moderna, Inc. (NASDAQ:MRNA) Stake Lifted by Northern Trust Corp - MarketBeat

01:36 AM
pulisher
12:57 PM

Moderna (MRNA) and Pfizer/BioNTech Vaccines Under FDA Review - GuruFocus

12:57 PM
pulisher
12:29 PM

FDA advisory panel to discuss makeup of updated COVID shots - Seeking Alpha

12:29 PM
pulisher
11:45 AM

MRNA Sees Surge in Options Activity with Notable Imbalance | MRNA Stock News - GuruFocus

11:45 AM
pulisher
11:10 AM

June 27th Options Now Available For Moderna (MRNA) - Nasdaq

11:10 AM
pulisher
10:40 AM

Moderna's Combo Flu and COVID Shot Shows Promise - El Paso Inc.

10:40 AM
pulisher
07:28 AM

197,500 Shares in Moderna, Inc. (NASDAQ:MRNA) Bought by Cutter Capital Management LP - MarketBeat

07:28 AM
pulisher
07:19 AM

Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025 | MRNA Stock News - GuruFocus

07:19 AM
pulisher
07:06 AM

Moderna to Present at Upcoming Bernstein's 41st Annual Strategic Decisions Conference (SDC) on May 29, 2025 - The Derrick

07:06 AM
pulisher
06:00 AM

RFK Jr. Takes Aim at Covid Shots for Kids, Worrying Vaccine Experts - Bloomberg.com

06:00 AM
pulisher
05:08 AM

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by PDT Partners LLC - MarketBeat

05:08 AM
pulisher
May 07, 2025

Moderna study shows immune response in older adults for a combo flu and COVID-19 shot - yoursun.com

May 07, 2025
pulisher
May 07, 2025

Combo flu and COVID-19 shot shows promise in new Moderna study - LiveNOW from FOX

May 07, 2025
pulisher
May 07, 2025

US FDA advisers to discuss COVID-19 vaccine recommendations on May 22 - marketscreener.com

May 07, 2025
pulisher
May 07, 2025

Moderna Vaccine Study - Tulsa World

May 07, 2025
pulisher
May 07, 2025

Cantor Fitzgerald L. P. Purchases New Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Dimensional Fund Advisors LP Has $69.34 Million Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 07, 2025
pulisher
May 07, 2025

BLI Banque de Luxembourg Investments Buys Shares of 15,000 Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 07, 2025
pulisher
May 07, 2025

GraniteShares adjusts Moderna ETP in upcoming consolidation By Investing.com - Investing.com UK

May 07, 2025
pulisher
May 06, 2025

This Week's Healthcare Earnings: Moderna, CVS, Hims & Hers - Law360

May 06, 2025
pulisher
May 06, 2025

Moderna, Pharma Stocks Fall as FDA Names Industry Critic as Top Vaccine Regulator - Barron's

May 06, 2025
pulisher
May 06, 2025

Moderna Sharpens Pipeline Focus as COVID-19 Vaccine Demand Ebbs in Q1 - The Globe and Mail

May 06, 2025
pulisher
May 06, 2025

Redburn Atlantic Adjusts Moderna Price Target to $53 From $52, Maintains Neutral Rating - marketscreener.com

May 06, 2025
pulisher
May 06, 2025

Banque Transatlantique SA Takes Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 06, 2025
pulisher
May 06, 2025

Public Employees Retirement Association of Colorado Trims Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 06, 2025
pulisher
May 06, 2025

mRNA Vaccines: Evolving Pipelines Across Infectious Disease, Oncology & Rare Disorders - openPR.com

May 06, 2025
pulisher
May 06, 2025

Moderna, Inc. (NASDAQ:MRNA) Stock Position Increased by Lido Advisors LLC - MarketBeat

May 06, 2025
pulisher
May 05, 2025

Price T Rowe Associates Inc. MD Has $44.62 Million Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 05, 2025
pulisher
May 05, 2025

Envestnet Asset Management Inc. Lowers Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 05, 2025
pulisher
May 05, 2025

On the Move: Moderna's Cronin Moves to Medtronic Diabetes - O'Dwyer's PR

May 05, 2025
pulisher
May 05, 2025

Ex-Moderna brand chief Kate Cronin joins Medtronic Diabetes as marketing lead - Medical Marketing and Media

May 05, 2025
pulisher
May 05, 2025

Moderna Sharpens Pipeline Focus As COVID-19 Vaccine Demand Ebbs In Q1 - Barchart.com

May 05, 2025
pulisher
May 05, 2025

The Manufacturers Life Insurance Company Acquires 267,990 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 05, 2025
pulisher
May 04, 2025

Moderna Stock Crumbles As Vaccine Troubles Rattle Its Topline - MSN

May 04, 2025
pulisher
May 04, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Pinebridge Investments L.P. - MarketBeat

May 04, 2025
pulisher
May 04, 2025

Moderna Q1 Earnings Ahead: Analysts expect loss amid increased regulatory scrutiny - MSN

May 04, 2025
pulisher
May 03, 2025

Moderna, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – MRNA - ACCESS Newswire

May 03, 2025
pulisher
May 03, 2025

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Aquatic Capital Management LLC - MarketBeat

May 03, 2025
pulisher
May 02, 2025

UBS Analyst Lowers Price Target for MRNA, Maintains Buy Rating | - GuruFocus

May 02, 2025
pulisher
May 02, 2025

XTX Topco Ltd Decreases Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 02, 2025
pulisher
May 02, 2025

Barclays Lowers Price Target on Moderna (MRNA) to $40.00 | MRNA Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Moderna Pivots To Increase Focus On Cancer Amid US Vaccine Policy Changes - insights.citeline.com

May 02, 2025
pulisher
May 02, 2025

Susquehanna Fundamental Investments LLC Invests $16.04 Million in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

May 02, 2025
pulisher
May 02, 2025

Moderna (MRNA) Price Target Lowered by RBC Capital | MRNA Stock News - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Moderna (MRNA) Target Price Cut by RBC Capital Amid Financial Up - GuruFocus

May 02, 2025
pulisher
May 02, 2025

Moderna (NasdaqGS:MRNA) Reports Decrease in Q1 Revenue and Net Loss - Yahoo Finance

May 02, 2025

Moderna Inc Azioni (MRNA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$19.42
price down icon 5.73%
$65.63
price down icon 3.88%
$33.10
price up icon 1.07%
$24.65
price up icon 1.48%
$94.78
price up icon 2.13%
biotechnology ONC
$235.94
price up icon 1.59%
Capitalizzazione:     |  Volume (24 ore):